A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding-Reference-Cited by-同舟云学术

A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding

Published:2016-06 Issue:6 Volume:98 Page:1159-1169
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Painter Jodie N.,Kaufmann Susanne,O’Mara Tracy A.,Hillman Kristine M.,Sivakumaran Haran,Darabi Hatef,Cheng Timothy H.T.,Pearson John,Kazakoff Stephen,Waddell Nicola,Hoivik Erling A.,Goode Ellen L.,Scott Rodney J.,Tomlinson Ian,Dunning Alison M.,Easton Douglas F.,French Juliet D.,Salvesen Helga B.,Pollock Pamela M.,Thompson Deborah J.,Spurdle Amanda B.,Edwards Stacey L.

Publisher

Elsevier BV

Subject

Genetics(clinical),Genetics

Reference65 articles.

1. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11;Ferlay,2013

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

3. Genome-wide association study identifies a common variant associated with risk of endometrial cancer;Spurdle;Nat. Genet.,2011

4. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk;Painter;Hum. Mol. Genet.,2015

5. CYP19A1 fine-mapping and Mendelian randomisation: estradiol is causal for endometrial cancer;Thompson;Endocr. Relat. Cancer,2015

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The experimental significance of isorhamnetin as an effective therapeutic option for cancer: A comprehensive analysis;Biomedicine & Pharmacotherapy;2024-07

2. Hidden secrets of the cancer genome: unlocking the impact of non-coding mutations in gene regulatory elements;Cellular and Molecular Life Sciences;2024-06-20

3. Yin Yang 1 expression predicts a favourable survival in diffuse large B-cell lymphoma;Heliyon;2024-01

4. Discovering Deleterious Single Nucleotide Polymorphisms of Human AKT1 Oncogene: An In Silico Study;Life;2023-07-10

5. Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression;Journal of Nanobiotechnology;2023-07-05